Startups
K2 HealthVentures (K2HV) is a flexible, long-term provider of debt and equity capital to venture and growth stage companies in the life sciences and healthcare industries. We invest in both private and public companies.
We started K2HV with dual goals of profit and purpose – to help fuel the growth of life sciences companies and the advancement of new healthcare treatment options, and ultimately to improve the lives of patients.
We bring together a unique combination of business acumen, debt and equity investing experience, and deep knowledge of life sciences.
Our fund has an initial equity commitment of $400 million, and total investable capital is expected to approach $1 billion. Our capital base is permanent, which enables us to be a long-term oriented, strategic partner.
We started K2HV with dual goals of profit and purpose – to help fuel the growth of life sciences companies and the advancement of new healthcare treatment options, and ultimately to improve the lives of patients.
We bring together a unique combination of business acumen, debt and equity investing experience, and deep knowledge of life sciences.
Our fund has an initial equity commitment of $400 million, and total investable capital is expected to approach $1 billion. Our capital base is permanent, which enables us to be a long-term oriented, strategic partner.
Overview
Location
United States, Massachusetts, Boston
Employees
11-50
Founded date
2018
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 20, 2025 | Umoja Biopharma Raises $100M in Series C Financing | Umoja Biopharma, a Seattle, WA-based clinical-stage company which specializes in vivo cell therapies, raised $100M Series C financing. The round was led by Double Point Ventures and DCVC Bio, with participation from new and existing investo... |
| Nov 29, 2022 | DispatchHealth Looks To Expand In-home Care With More Than $330M in Financing | About $4 trillion is spent annually on the healthcare industry in the U.S., and will likely top $6 trillion by 2028. A large chunk of this money is for care in traditional brick and mortar facilities, said DispatchHealth CEO Dr. Mark Prathe... |
| Jul 28, 2022 | Elevation Oncology Secures $50M Loan Facility with K2 HealthVentures | What You Should Know: Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior ... |
| Jul 13, 2021 | ASLAN Pharmaceuticals : Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures | SINGAPORE, July 13, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it has... |
| Jul 13, 2021 | ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures | ASLAN Pharmaceuticals Limited announced that it has closed a secured loan facility provided by K2 HealthVentures (K2HV). Under the terms of the facility, K2HV will provide ASLAN up to $45 million of secured debt financing. The facility cons... |
| May 8, 2021 | Cricket Health Secures $83.5M to Expand Value-Based Kidney Care Model to Health Plans | What You Should Know: – Cricket Health, a San Francisco, CA-based provider of value-based kidney care with a clinically-proven approach to managing chronic kidney disease (CKD) and end-stage kidney disease (ESKD), today announced it has rai... |
| May 23, 2019 | K2 HealthVentures Launches New Investment Firm | K2 HealthVentures (K2HV) has launched a new specialty finance firm that will provide long-term debt, equity, and intellectual capital to private and public life sciences and healthcare companies. With $400M initial capital commitment, which... |
Reviews 0
FAQ about K2 HealthVentures
When was K2 HealthVentures founded?
K2 HealthVentures was founded in 2018.
What has the press written about K2 HealthVentures?
Parsers VC has collected 8 articles mentioning K2 HealthVentures, among them “Umoja Biopharma Raises $100M in Series C Financing” (Jan 20, 2025) and “DispatchHealth Looks To Expand In-home Care With More Than $330M in Financing” (Nov 29, 2022).
Is K2 HealthVentures still active?
Yes, K2 HealthVentures is active; its latest activity on Parsers VC dates from Jan 20, 2025.